Akrano Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 14 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 106.87%
- Profit Growth -1460.77%
- Ebitda -1500.89%
- Net Worth -1199.62%
- Total Assets -14.04%
About Akrano Life Sciences
Akrano Life Sciences Private Limited (ALSPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 January 2018 (Seven years 14 days old ). Its registered office is in Pune, Maharashtra, India.
The Corporate was formerly known as Algrus Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vimal Jha, Nisha Sharma, Rakesh Ratan, and One other member serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74110PN2018PTC174423
-
Company No.
174423
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Jan 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Akrano Life Sciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vimal Jha
|
Director | 17-Jan-2018 | Current |
|
Nisha Sharma
|
Additional Director | Current | |
|
Rakesh Ratan
|
Director | 17-Aug-2024 | Current |
|
Bhavana Prasad
|
Director | 15-Nov-2021 | Current |
Financial Performance of Akrano Life Sciences.
Akrano Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 106.87% increase. The company also saw a substantial fall in profitability, with a 1460.77% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1199.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Akrano Life Sciences?
Unlock access to Akrano Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Gennec Life Sciences LlpVimal Jha is a mutual person
-
Hrn H-Bot Solutions Private Limited
Nisha Sharma is a mutual person
-
Acia Lifescience Private Limited
Rakesh Ratan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Akrano Life Sciences?
Unlock and access historical data on people associated with Akrano Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Akrano Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akrano Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
